Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | ataxin-2 like protein, putative | 0.021 | 0.1818 | 1 |
Trichomonas vaginalis | low molecular weight protein-tyrosine-phosphatase, putative | 0.0588 | 0.5807 | 1 |
Schistosoma mansoni | Smad4 | 0.0067 | 0.0316 | 0.0151 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.021 | 0.1818 | 1 |
Echinococcus multilocularis | Smad4 | 0.0067 | 0.0316 | 0.0409 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.021 | 0.1818 | 1 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0114 | 0.0811 | 0.3927 |
Brugia malayi | RNA binding protein | 0.0062 | 0.0259 | 0.0259 |
Trichomonas vaginalis | low molecular weight protein tyrosine phosphatase, putative | 0.0588 | 0.5807 | 1 |
Echinococcus granulosus | mothers against decapentaplegic 5 | 0.0067 | 0.0316 | 0.0409 |
Brugia malayi | MH1 domain containing protein | 0.0067 | 0.0316 | 0.0316 |
Schistosoma mansoni | smad | 0.0067 | 0.0316 | 0.0151 |
Brugia malayi | hypothetical protein | 0.021 | 0.1818 | 0.1818 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0114 | 0.0811 | 0.3927 |
Echinococcus multilocularis | smad | 0.0067 | 0.0316 | 0.0409 |
Schistosoma mansoni | hypothetical protein | 0.0195 | 0.1665 | 0.3707 |
Brugia malayi | MH2 domain containing protein | 0.0067 | 0.0316 | 0.0316 |
Onchocerca volvulus | 0.0588 | 0.5807 | 1 | |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0195 | 0.1665 | 0.1665 |
Loa Loa (eye worm) | phosphotyrosine protein phosphatase | 0.0588 | 0.5807 | 0.5807 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0195 | 0.1665 | 0.1665 |
Mycobacterium tuberculosis | Phosphotyrosine protein phosphatase PtpA (protein-tyrosine-phosphatase) (PTPase) (LMW phosphatase) | 0.0407 | 0.3896 | 1 |
Brugia malayi | Smad1 | 0.0067 | 0.0316 | 0.0316 |
Echinococcus granulosus | Ataxin 2 N terminaldomain containing protein | 0.0094 | 0.0599 | 0.2422 |
Loa Loa (eye worm) | hypothetical protein | 0.0421 | 0.4051 | 0.4051 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0421 | 0.4051 | 0.4051 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.021 | 0.1818 | 1 |
Echinococcus granulosus | smad | 0.0067 | 0.0316 | 0.0409 |
Echinococcus multilocularis | GPCR, family 2 | 0.0195 | 0.1665 | 1 |
Echinococcus multilocularis | Ataxin 2, N terminal,domain containing protein | 0.0094 | 0.0599 | 0.2422 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0067 | 0.0316 | 0.0316 |
Trypanosoma brucei | low molecular weight protein tyrosine phosphatase, putative | 0.0181 | 0.1519 | 0.7034 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0195 | 0.1665 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0986 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0195 | 0.1665 | 0.1665 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0114 | 0.0811 | 0.3927 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0617 | 0.6107 | 0.6107 |
Loa Loa (eye worm) | Smad1 | 0.0067 | 0.0316 | 0.0316 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0062 | 0.0259 | 0.0259 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0195 | 0.1665 | 0.1665 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0114 | 0.0811 | 0.0811 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0114 | 0.0811 | 0.3927 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0114 | 0.0811 | 0.3927 |
Trichomonas vaginalis | low molecular weight protein-tyrosine-phosphatase, putative | 0.0588 | 0.5807 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0094 | 0.0599 | 0.0898 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0181 | 0.1519 | 0.7034 |
Loa Loa (eye worm) | RNA binding protein | 0.0062 | 0.0259 | 0.0259 |
Trichomonas vaginalis | low molecular weight protein tyrosine phosphatase, putative | 0.0588 | 0.5807 | 1 |
Brugia malayi | N-terminal motif family protein | 0.039 | 0.3715 | 0.3715 |
Entamoeba histolytica | protein tyrosine phosphatase, putative | 0.0588 | 0.5807 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0181 | 0.1519 | 0.7034 |
Schistosoma mansoni | hypothetical protein | 0.0195 | 0.1665 | 0.3707 |
Brugia malayi | MH1 domain containing protein | 0.0067 | 0.0316 | 0.0316 |
Brugia malayi | hypothetical protein | 0.0135 | 0.1035 | 0.1035 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.0067 | 0.0316 | 0.0316 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.021 | 0.1818 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0195 | 0.1665 | 0.3707 |
Schistosoma mansoni | smad1 5 8 and | 0.0067 | 0.0316 | 0.0151 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0195 | 0.1665 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0421 | 0.4051 | 1 |
Brugia malayi | TAR-binding protein | 0.0062 | 0.0259 | 0.0259 |
Echinococcus multilocularis | mothers against decapentaplegic 5 | 0.0067 | 0.0316 | 0.0409 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0062 | 0.0259 | 0.0259 |
Mycobacterium ulcerans | phosphotyrosine protein phosphatase PtpA | 0.0588 | 0.5807 | 0.5 |
Schistosoma mansoni | smad1 5 8 and | 0.0067 | 0.0316 | 0.0151 |
Brugia malayi | Low molecular weight phosphotyrosine protein phosphatase containing protein | 0.0588 | 0.5807 | 0.5807 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.021 | 0.1818 | 1 |
Echinococcus granulosus | GPCR family 2 | 0.0195 | 0.1665 | 1 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0114 | 0.0811 | 0.3927 |
Brugia malayi | MH2 domain containing protein | 0.0067 | 0.0316 | 0.0316 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0195 | 0.1665 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0195 | 0.1665 | 0.3707 |
Loa Loa (eye worm) | hypothetical protein | 0.0617 | 0.6107 | 0.6107 |
Loa Loa (eye worm) | TAR-binding protein | 0.0062 | 0.0259 | 0.0259 |
Echinococcus granulosus | Smad4 | 0.0067 | 0.0316 | 0.0409 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0195 | 0.1665 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.021 | 0.1818 | 0.1818 |
Schistosoma mansoni | smad1 5 8 and | 0.0067 | 0.0316 | 0.0151 |
Loa Loa (eye worm) | hypothetical protein | 0.039 | 0.3715 | 0.3715 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0617 | 0.6107 | 0.6107 |
Schistosoma mansoni | TGF-beta signal transducer Smad2 | 0.0067 | 0.0316 | 0.0151 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.021 | 0.1818 | 1 |
Echinococcus granulosus | TGF beta signal transducer SmadC | 0.0067 | 0.0316 | 0.0409 |
Brugia malayi | isocitrate dehydrogenase | 0.0114 | 0.0811 | 0.0811 |
Echinococcus multilocularis | TGF beta signal transducer SmadC | 0.0067 | 0.0316 | 0.0409 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0114 | 0.0811 | 0.1456 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0617 | 0.6107 | 0.6107 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0986 | 1 | 1 |
Brugia malayi | Isocitrate dehydrogenase | 0.0114 | 0.0811 | 0.0811 |
Trichomonas vaginalis | low molecular weight protein-tyrosine-phosphatase, putative | 0.0588 | 0.5807 | 1 |
Leishmania major | hypothetical protein, conserved | 0.021 | 0.1818 | 1 |
Entamoeba histolytica | protein tyrosine phosphatase, putative | 0.0588 | 0.5807 | 0.5 |
Giardia lamblia | Low molecular weight protein-tyrosine-phosphatase | 0.0588 | 0.5807 | 0.5 |
Trichomonas vaginalis | low molecular weight protein tyrosine phosphatase, putative | 0.0588 | 0.5807 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0181 | 0.1519 | 0.7034 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.